Expression of CIAPIN1 gene in BMMNC of patients with leukemia.
- Author:
Bin LI
1
;
Qing-Hua LI
;
Ya-Ni LIN
;
Wei-Na JIN
;
Tian-Xiang PANG
Author Information
1. State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Disease Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
- Publication Type:Journal Article
- MeSH:
Adult;
Bone Marrow Cells;
metabolism;
Case-Control Studies;
Female;
Gene Expression Regulation, Leukemic;
Humans;
Intracellular Signaling Peptides and Proteins;
genetics;
Leukemia;
genetics;
metabolism;
pathology;
Leukemia, Lymphocytic, Chronic, B-Cell;
genetics;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive;
genetics;
Leukemia, Myeloid, Acute;
genetics;
Male;
Middle Aged;
Young Adult
- From:
Journal of Experimental Hematology
2011;19(3):570-573
- CountryChina
- Language:Chinese
-
Abstract:
This study was aimed to investigate the expression level of CIAPIN1 mRNA in leukemia patients and explore its significance in leukemias. The fresh bone marrow was collected from 112 newly diagnosed leukemia patients, the total RNA was extracted by means of TRIzoL, the cDNA was synthesized, the expression of CIAPIN1 mRNA was detected by real-time quantitative PCR using β-actin as internal reference; 10 normal healthy persons were selected as controls. The results showed that the expression of CIAPIN1 mRNA was statistically higher in acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL) and chronic phase chronic myeloid leukemia (CML) patients than that in normal persons (p < 0.05); but there was no statistical difference between chronic lymphocytic leukemia (CLL) and normal persons (p > 0.05). It is concluded that the CIAPIN1 gene higher expresses in MNC of newly diagnosed leukemia patients, up-regulation of CIAPIN1 expression may play an important role in pathogenesis of leukemia.
